CVE-2013-3154

Description

The signature-update functionality in Windows Defender on Microsoft Windows 7 and Windows Server 2008 R2 relies on an incorrect pathname, which allows local users to gain privileges via a Trojan horse application in the %SYSTEMDRIVE% top-level directory, aka "Microsoft Windows 7 Defender Improper Pathname Vulnerability."

Category

6.9
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 2.32% Top 20%
Vendor Advisory microsoft.com Vendor Advisory technet.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://docs.microsoft.com/en-us/security-updates/securitybulletins/2013/ms13-058 vendor advisory
http://blogs.technet.com/b/srd/archive/2013/07/09/assessing-risk-for-the-july-2013-security-updates.aspx vendor advisory
https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3Adef%3A17253 vdb entry signature
http://www.us-cert.gov/ncas/alerts/TA13-190A third party advisory us government resource

Frequently Asked Questions

What is the severity of CVE-2013-3154?
CVE-2013-3154 has been scored as a medium severity vulnerability.
How to fix CVE-2013-3154?
To fix CVE-2013-3154, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2013-3154 being actively exploited in the wild?
It is possible that CVE-2013-3154 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.